GNLY: Difference between revisions
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
m (Bot: HTTP→HTTPS) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
'''Granulysin''', also known as '''GNLY''', is a [[protein]] which in humans is encoded by the ''GNLY'' [[gene]].<ref name="entrez"/> | |||
== Function == | |||
Granulysin is a [[protein]] present in cytotoxic granules of [[cytotoxic T cells]] and [[natural killer cells]]. Granulysin is a member of the [[saposin]]-like protein (SAPLIP) family and is released from cytotoxic T cells upon antigen stimulation. Granulysin has [[antimicrobial]] activity against [[M. tuberculosis]] and other organisms. Granulysin is alternatively spliced, resulting in the NKG5 and 519 transcripts.<ref name="entrez">{{cite web | title = Entrez Gene: GNLY granulysin| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=10578| accessdate = }}</ref> | |||
Granulysin is a cytolytic and proinflammatory molecule first identified by a screen for genes expressed “late” (3–5 days) after activation of human peripheral blood mononuclear cells.<ref name="pmid2434598">{{cite journal |vauthors=Jongstra J, Schall TJ, Dyer BJ, Clayberger C, Jorgensen J, Davis MM, Krensky AM | title = The isolation and sequence of a novel gene from a human functional T cell line | journal = J. Exp. Med. | volume = 165 | issue = 3 | pages = 601–14 |date=March 1987 | pmid = 2434598 | pmc = 2188281 | doi = 10.1084/jem.165.3.601| url = }}</ref> Granulysin is present in cytolytic granules of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Granulysin is made as a 15 kD molecule, and a portion of it is cleaved at both the amino and carboxy termini into a 9 kD form. The 9 kD form is released by receptor-mediated granule exocytosis while the 15 kD form is constitutively secreted. Recombinant 9 kD granulysin is broadly cytolytic against tumors and microbes, including gram positive and gram negative bacteria, fungi/yeast and parasites.<ref name="pmid9756476">{{cite journal |vauthors=Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melián A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL | title = An antimicrobial activity of cytolytic T cells mediated by granulysin | journal = Science | volume = 282 | issue = 5386 | pages = 121–5 |date=October 1998 | pmid = 9756476 | doi = 10.1126/science.282.5386.121 | url = }}</ref> 9kD granulysin is also a chemoattractant for T lymphocytes, monocytes, and other inflammatory cells and activates the expression of a number of cytokines, including RANTES, MCP-1, MCP-3, MIP-1α, IL-10, IL-1, IL-6 and IFNα.<ref name="pmid15843520">{{cite journal |vauthors=Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM | title = Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator | journal = J. Immunol. | volume = 174 | issue = 9 | pages = 5243–8 |date=May 2005 | pmid = 15843520 | doi = 10.4049/jimmunol.174.9.5243| url = http://www.jimmunol.org/cgi/content/abstract/174/9/5243 }}</ref> Mice do not have a granulysin homolog, but transgenic mice expressing human granulysin have been engineered.<ref name="pmid17182542">{{cite journal |vauthors=Huang LP, Lyu SC, Clayberger C, Krensky AM | title = Granulysin-Mediated Tumor Rejection in Transgenic Mice | journal = J. Immunol. | volume = 178 | issue = 1 | pages = 77–84 |date=January 2007 | pmid = 17182542 | doi = 10.4049/jimmunol.178.1.77| url = http://www.jimmunol.org/cgi/content/full/178/1/77| pmc = 2664664 }}</ref> Granulysin has been implicated in a myriad of diseases including [[infection]], [[cancer]], [[Organ transplantation|transplantation]], [[autoimmunity]], skin and reproductive maladies.<ref name="pmid19254247">{{cite journal |vauthors=Krensky AM, Clayberger C | title = Biology and clinical relevance of granulysin | journal = Tissue Antigens | volume = 73 | issue = 3 | pages = 193–8 |date=March 2009 | pmid = 19254247 | doi = 10.1111/j.1399-0039.2008.01218.x | url = | pmc = 2679253 }}</ref> | |||
{{ | |||
| | |||
| | |||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
{{PBB_Further_reading | {{PBB_Further_reading | ||
| citations = | | citations = | ||
*{{cite journal | | *{{cite journal |vauthors=Peña SV, Krensky AM |title=Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity |journal=Semin. Immunol. |volume=9 |issue= 2 |pages= 117–25 |year= 1997 |pmid= 9194222 |doi= 10.1006/smim.1997.0061 }} | ||
*{{cite journal | author=Krensky AM |title=Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells | *{{cite journal | author=Krensky AM |title=Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells |journal=Biochem. Pharmacol. |volume=59 |issue= 4 |pages= 317–20 |year= 2000 |pmid= 10644038 |doi=10.1016/S0006-2952(99)00177-X }} | ||
*{{cite journal | | *{{cite journal |vauthors=Donlon TA, Krensky AM, Clayberger C |title=Localization of the human T lymphocyte activation gene 519 (D2S69E) to chromosome 2p12----q11 |journal=Cytogenet. Cell Genet. |volume=53 |issue= 4 |pages= 230–1 |year= 1990 |pmid= 2209093 |doi=10.1159/000132938 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Yabe T, McSherry C, Bach FH, Houchins JP |title=A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein |journal=J. Exp. Med. |volume=172 |issue= 4 |pages= 1159–63 |year= 1990 |pmid= 2212946 |doi=10.1084/jem.172.4.1159 | pmc=2188624 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Jongstra J, Schall TJ, Dyer BJ |title=The isolation and sequence of a novel gene from a human functional T cell line |journal=J. Exp. Med. |volume=165 |issue= 3 |pages= 601–14 |year= 1987 |pmid= 2434598 |doi=10.1084/jem.165.3.601 | pmc=2188281 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Houchins JP, Kricek F, Chujor CS |title=Genomic structure of NKG5, a human NK and T cell-specific activation gene |journal=Immunogenetics |volume=37 |issue= 2 |pages= 102–7 |year= 1993 |pmid= 8423048 |doi=10.1007/BF00216832 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Peña SV, Hanson DA, Carr BA |title=Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins |journal=J. Immunol. |volume=158 |issue= 6 |pages= 2680–8 |year= 1997 |pmid= 9058801 |doi= |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Stenger S, Hanson DA, Teitelbaum R |title=An antimicrobial activity of cytolytic T cells mediated by granulysin |journal=Science |volume=282 |issue= 5386 |pages= 121–5 |year= 1998 |pmid= 9756476 |doi=10.1126/science.282.5386.121 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Hanson DA, Kaspar AA, Poulain FR, Krensky AM |title=Biosynthesis of granulysin, a novel cytolytic molecule |journal=Mol. Immunol. |volume=36 |issue= 7 |pages= 413–22 |year= 1999 |pmid= 10449094 |doi=10.1016/S0161-5890(99)00063-2 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Kaspar AA, Okada S, Kumar J |title=A distinct pathway of cell-mediated apoptosis initiated by granulysin |journal=J. Immunol. |volume=167 |issue= 1 |pages= 350–6 |year= 2001 |pmid= 11418670 |doi= 10.4049/jimmunol.167.1.350|display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Kitamura N, Koshiba M, Horie O, Ryo R |title=Expression of granulysin mRNA in the human megakaryoblastic leukemia cell line CMK |journal=Acta Haematol. |volume=108 |issue= 1 |pages= 13–8 |year= 2002 |pmid= 12145461 |doi=10.1159/000063061 }} | ||
*{{cite journal | | *{{cite journal |vauthors=Ma LL, Spurrell JC, Wang JF |title=CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15 |journal=J. Immunol. |volume=169 |issue= 10 |pages= 5787–95 |year= 2003 |pmid= 12421959 |doi= 10.4049/jimmunol.169.10.5787|display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Ericson KG, Fadeel B, Andersson M |title=Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis |journal=Hum. Genet. |volume=112 |issue= 1 |pages= 98–9 |year= 2003 |pmid= 12483306 |doi= 10.1007/s00439-002-0841-0 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Anderson DH, Sawaya MR, Cascio D |title=Granulysin crystal structure and a structure-derived lytic mechanism |journal=J. Mol. Biol. |volume=325 |issue= 2 |pages= 355–65 |year= 2003 |pmid= 12488100 |doi=10.1016/S0022-2836(02)01234-2 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Gansert JL, Kiessler V, Engele M |title=Human NKT cells express granulysin and exhibit antimycobacterial activity |journal=J. Immunol. |volume=170 |issue= 6 |pages= 3154–61 |year= 2003 |pmid= 12626573 |doi= 10.4049/jimmunol.170.6.3154|display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Ogawa K, Takamori Y, Suzuki K |title=Granulysin in human serum as a marker of cell-mediated immunity |journal=Eur. J. Immunol. |volume=33 |issue= 7 |pages= 1925–33 |year= 2003 |pmid= 12884856 |doi= 10.1002/eji.200323977 |display-authors=etal}} | ||
*{{cite journal | | *{{cite journal |vauthors=Kotsch K, Mashreghi MF, Bold G |title=Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection |journal=Transplantation |volume=77 |issue= 12 |pages= 1866–75 |year= 2004 |pmid= 15223905 |doi=10.1097/01.TP.0000131157.19937.3F |display-authors=etal}} | ||
}} | }} | ||
{{refend}} | {{refend}} | ||
{{PDB Gallery|geneid=10578}} | |||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | |||
{{PBB_Controls | |||
| update_page = yes | |||
| require_manual_inspection = no | |||
| update_protein_box = yes | |||
| update_summary = yes | |||
| update_citations = yes | |||
}} | |||
{{ | {{gene-2-stub}} | ||
Latest revision as of 08:53, 31 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Granulysin, also known as GNLY, is a protein which in humans is encoded by the GNLY gene.[1]
Function
Granulysin is a protein present in cytotoxic granules of cytotoxic T cells and natural killer cells. Granulysin is a member of the saposin-like protein (SAPLIP) family and is released from cytotoxic T cells upon antigen stimulation. Granulysin has antimicrobial activity against M. tuberculosis and other organisms. Granulysin is alternatively spliced, resulting in the NKG5 and 519 transcripts.[1]
Granulysin is a cytolytic and proinflammatory molecule first identified by a screen for genes expressed “late” (3–5 days) after activation of human peripheral blood mononuclear cells.[2] Granulysin is present in cytolytic granules of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Granulysin is made as a 15 kD molecule, and a portion of it is cleaved at both the amino and carboxy termini into a 9 kD form. The 9 kD form is released by receptor-mediated granule exocytosis while the 15 kD form is constitutively secreted. Recombinant 9 kD granulysin is broadly cytolytic against tumors and microbes, including gram positive and gram negative bacteria, fungi/yeast and parasites.[3] 9kD granulysin is also a chemoattractant for T lymphocytes, monocytes, and other inflammatory cells and activates the expression of a number of cytokines, including RANTES, MCP-1, MCP-3, MIP-1α, IL-10, IL-1, IL-6 and IFNα.[4] Mice do not have a granulysin homolog, but transgenic mice expressing human granulysin have been engineered.[5] Granulysin has been implicated in a myriad of diseases including infection, cancer, transplantation, autoimmunity, skin and reproductive maladies.[6]
References
- ↑ 1.0 1.1 "Entrez Gene: GNLY granulysin".
- ↑ Jongstra J, Schall TJ, Dyer BJ, Clayberger C, Jorgensen J, Davis MM, Krensky AM (March 1987). "The isolation and sequence of a novel gene from a human functional T cell line". J. Exp. Med. 165 (3): 601–14. doi:10.1084/jem.165.3.601. PMC 2188281. PMID 2434598.
- ↑ Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melián A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL (October 1998). "An antimicrobial activity of cytolytic T cells mediated by granulysin". Science. 282 (5386): 121–5. doi:10.1126/science.282.5386.121. PMID 9756476.
- ↑ Deng A, Chen S, Li Q, Lyu SC, Clayberger C, Krensky AM (May 2005). "Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator". J. Immunol. 174 (9): 5243–8. doi:10.4049/jimmunol.174.9.5243. PMID 15843520.
- ↑ Huang LP, Lyu SC, Clayberger C, Krensky AM (January 2007). "Granulysin-Mediated Tumor Rejection in Transgenic Mice". J. Immunol. 178 (1): 77–84. doi:10.4049/jimmunol.178.1.77. PMC 2664664. PMID 17182542.
- ↑ Krensky AM, Clayberger C (March 2009). "Biology and clinical relevance of granulysin". Tissue Antigens. 73 (3): 193–8. doi:10.1111/j.1399-0039.2008.01218.x. PMC 2679253. PMID 19254247.
Further reading
- Peña SV, Krensky AM (1997). "Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity". Semin. Immunol. 9 (2): 117–25. doi:10.1006/smim.1997.0061. PMID 9194222.
- Krensky AM (2000). "Granulysin: a novel antimicrobial peptide of cytolytic T lymphocytes and natural killer cells". Biochem. Pharmacol. 59 (4): 317–20. doi:10.1016/S0006-2952(99)00177-X. PMID 10644038.
- Donlon TA, Krensky AM, Clayberger C (1990). "Localization of the human T lymphocyte activation gene 519 (D2S69E) to chromosome 2p12----q11". Cytogenet. Cell Genet. 53 (4): 230–1. doi:10.1159/000132938. PMID 2209093.
- Yabe T, McSherry C, Bach FH, Houchins JP (1990). "A cDNA clone expressed in natural killer and T cells that likely encodes a secreted protein". J. Exp. Med. 172 (4): 1159–63. doi:10.1084/jem.172.4.1159. PMC 2188624. PMID 2212946.
- Jongstra J, Schall TJ, Dyer BJ, et al. (1987). "The isolation and sequence of a novel gene from a human functional T cell line". J. Exp. Med. 165 (3): 601–14. doi:10.1084/jem.165.3.601. PMC 2188281. PMID 2434598.
- Houchins JP, Kricek F, Chujor CS, et al. (1993). "Genomic structure of NKG5, a human NK and T cell-specific activation gene". Immunogenetics. 37 (2): 102–7. doi:10.1007/BF00216832. PMID 8423048.
- Peña SV, Hanson DA, Carr BA, et al. (1997). "Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins". J. Immunol. 158 (6): 2680–8. PMID 9058801.
- Stenger S, Hanson DA, Teitelbaum R, et al. (1998). "An antimicrobial activity of cytolytic T cells mediated by granulysin". Science. 282 (5386): 121–5. doi:10.1126/science.282.5386.121. PMID 9756476.
- Hanson DA, Kaspar AA, Poulain FR, Krensky AM (1999). "Biosynthesis of granulysin, a novel cytolytic molecule". Mol. Immunol. 36 (7): 413–22. doi:10.1016/S0161-5890(99)00063-2. PMID 10449094.
- Kaspar AA, Okada S, Kumar J, et al. (2001). "A distinct pathway of cell-mediated apoptosis initiated by granulysin". J. Immunol. 167 (1): 350–6. doi:10.4049/jimmunol.167.1.350. PMID 11418670.
- Kitamura N, Koshiba M, Horie O, Ryo R (2002). "Expression of granulysin mRNA in the human megakaryoblastic leukemia cell line CMK". Acta Haematol. 108 (1): 13–8. doi:10.1159/000063061. PMID 12145461.
- Ma LL, Spurrell JC, Wang JF, et al. (2003). "CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15". J. Immunol. 169 (10): 5787–95. doi:10.4049/jimmunol.169.10.5787. PMID 12421959.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Ericson KG, Fadeel B, Andersson M, et al. (2003). "Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis". Hum. Genet. 112 (1): 98–9. doi:10.1007/s00439-002-0841-0. PMID 12483306.
- Anderson DH, Sawaya MR, Cascio D, et al. (2003). "Granulysin crystal structure and a structure-derived lytic mechanism". J. Mol. Biol. 325 (2): 355–65. doi:10.1016/S0022-2836(02)01234-2. PMID 12488100.
- Gansert JL, Kiessler V, Engele M, et al. (2003). "Human NKT cells express granulysin and exhibit antimycobacterial activity". J. Immunol. 170 (6): 3154–61. doi:10.4049/jimmunol.170.6.3154. PMID 12626573.
- Ogawa K, Takamori Y, Suzuki K, et al. (2003). "Granulysin in human serum as a marker of cell-mediated immunity". Eur. J. Immunol. 33 (7): 1925–33. doi:10.1002/eji.200323977. PMID 12884856.
- Kotsch K, Mashreghi MF, Bold G, et al. (2004). "Enhanced granulysin mRNA expression in urinary sediment in early and delayed acute renal allograft rejection". Transplantation. 77 (12): 1866–75. doi:10.1097/01.TP.0000131157.19937.3F. PMID 15223905.
This article on a gene on human chromosome 2 is a stub. You can help Wikipedia by expanding it. |